Bacterial Cellulose Solutions, Inc.

To become the 1st US FDA approved ISO-13485 bacterial cellulose research and developer of unrealized medical applications in North America.

Company Summary

Bacterial Cellulose Solutions produces a propreitary bacterial cellulose wound device including 6 filed patents that offers superior properties including high strength, flexibility, temperature control, breathability & prevention of undesired bacterial transfer thru the media. Bacterial cellulose has a 25 year history with the FDA, and our strategy will provide unmet medical solutions such as the 1st tympanic membrane graft & skull base patch.

Team

  • Dana Oliver
    President & Co-founder

    Dana A. Oliver is an expert in innovation leadership with over 30 years experience in medical device research & development. He has over 40 patent applications & has been granted 26 patents to date. He helped grow Medtronic Surgical Technologies from $100 M to approximately $2 B annually. He is the author of 2 innovation leadership books "Mantra Design - Innovate, Buy, or Die!" & "Mantra Leadership - Don't Become the Emperor with No Clothes!"

  • Ethan G. Sherman PhD
    Chief Technology Officer & Co-founder

    7 years medical device experience at Medtronic Surgical Technologies including 7 patents, numerous publications and bacterial cellulose inventor.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free